Photo of Professor Ainhoa Mielgo Iza

Professor Ainhoa Mielgo Iza

Professor in Cancer Biology Molecular & Clinical Cancer Medicine

    Research

    Research Overview

    http://mielgolab.org/

    Tumour-stroma interactions

    Dr Ainhoa Mielgo’s laboratory focuses on investigating how tumour cells interact with the non-cancerous cells that surround cancer cells, that include fibroblasts and immune cells and form the tumour stroma. The tumour stroma plays a key role in cancer progression, metastasis and resistance to therapies. Ainhoa's team is interested in understanding the complex crosstalk between stromal, immune and tumour cells with the aim to identify physiologically relevant targets and develop more effective treatments for cancer patients. To achieve this goal, her laboratory uses a combination of innovative technologies established in her lab, including pre-clinical tumour models, patient samples, co-culture cell-based assays, quantitative proteomics, scRNA sequencing, bioinformatics, and flow and mass cytometry.

    Drug resistance & Metastasis

    Tumour immunity

    Research Grants

    Assessing Gas6+ neutrophils in the blood of pancreatic cancer patients undergoing chemotherapy to generate evidence for targeting Gas6/AXL signalling in patients

    THE CLATTERBRIDGE CANCER CENTRE NHS FOUNDATION TRUST (UK)

    September 2023 - March 2025

    Research fees for Maidinaimu Abudula 201450341

    CHINA SCHOLARSHIP COUNCIL (CSC)(CHINA) 🚩

    October 2021 - September 2024

    Function of stroma-derived gas6 in pancreatic cancer progression and metastasis.

    NORTH WEST CANCER RESEARCH INCORPORATING CLATTERBRIDGE CANCER RESEARCH (UK)

    December 2019 - November 2023

    Studying the impact of a non-canonical CRAF/PLK1 signalling pathway in desmoplasia and pancreatic cancer progression

    WELLCOME TRUST (UK)

    April 2014 - December 2019

    Role of monocytes in the metastatic process: identification of novel molecular targets to fight pancreatic cancer

    PANCREATIC CANCER RESEARCH FUND (UK)

    July 2015 - June 2019

    Multi-modal high resolution preclinical PET+SPECT+CT scanner

    WELLCOME TRUST (UK)

    July 2018 - June 2024

    Bench fees for Mr Sufyan M A El Hashani 201182871

    LIBYAN EMBASSY IN LONDON🚩

    October 2020 - September 2024